Bryostatin
group of chemical compounds
Bryostatins were first collected by JL Hartwell’s anticancer drug discovery group at the National Cancer Institute (NCI) by Jack Rudloe.
Names | |
---|---|
IUPAC name
(1S,3S,5Z,7R,8E,11S,12S,13E,15S,17R,20R,23R,25S)-25-Acetoxy-1,11,20-trihydroxy-17-[(1R)-1-hydroxyethyl]-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl (2E,4E)-2,4-octadienoate
| |
Identifiers | |
| |
3D model (JSmol)
|
|
ChEBI |
|
ChEMBL |
|
ChemSpider |
|
DrugBank |
|
KEGG |
|
PubChem CID
|
|
UNII |
|
| |
Properties | |
C47H68O17 | |
Molar mass | 905.04 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
Further reading
changeOther websites
change- Kilham C. "The Importance of Drugs From the Sea". Fox News Health. Archived from the original on 25 April 2012.
- "Bryostatin 1". Aphios Corporation. Archived from the original on 2013-12-20. Retrieved 2013-12-19.
- "Bryostatin 2". Aphios Corporation. Archived from the original on 2012-11-12. Retrieved 2022-07-16.
- "Bryostatin 3". Aphios Corporation. Archived from the original on 2013-12-20. Retrieved 2022-07-16.